These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17447898)

  • 41. Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis.
    Morita Y; Yamamura M; Nishida K; Harada S; Okamoto H; Inoue H; Ohmoto Y; Modlin RL; Makino H
    Arthritis Rheum; 1998 Feb; 41(2):306-14. PubMed ID: 9485089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet-derived growth factor-AA increases IL-1beta and IL-8 expression and activates NF-kappaB in rheumatoid fibroblast-like synoviocytes.
    Cheon H; Sun YK; Yu SJ; Lee YH; Ji JD; Song GG; Lee JH; Kim MK; Sohn J
    Scand J Immunol; 2004 Nov; 60(5):455-62. PubMed ID: 15541037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes.
    Kontny E; Szczepańska K; Kowalczewski J; Kurowska M; Janicka I; Marcinkiewicz J; Maśliński W
    Arthritis Rheum; 2000 Oct; 43(10):2169-77. PubMed ID: 11037876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis.
    Orosa B; González A; Mera A; Gómez-Reino JJ; Conde C
    Arthritis Rheum; 2012 Aug; 64(8):2460-70. PubMed ID: 22354754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of substance P on nitric oxide release in a rheumatoid arthritis model.
    O'Shaughnessy MC; Vetsika EK; Inglis JJ; Carleson J; Haigh R; Kidd BL; Winyard PG
    Inflamm Res; 2006 Jun; 55(6):236-40. PubMed ID: 16955242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of the type II collagen protein from Zaocys on cytokines production by synoviocytes in rats with adjuvant arthritis].
    Pang J; Li J; Wu XH; Wu HY
    Zhong Yao Cai; 2009 Apr; 32(4):556-60. PubMed ID: 19645241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
    Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
    Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha.
    Redlich K; Kiener HP; Schett G; Tohidast-Akrad M; Selzer E; Radda I; Stummvoll GH; Steiner CW; Gröger M; Bitzan P; Zenz P; Smolen JS; Steiner G
    Arthritis Rheum; 2001 Feb; 44(2):266-74. PubMed ID: 11229456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
    Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
    Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes.
    Roman-Blas JA; Contreras-Blasco MA; Largo R; Alvarez-Soria MA; Castañeda S; Herrero-Beaumont G
    Eur J Pharmacol; 2009 Nov; 623(1-3):125-31. PubMed ID: 19765584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
    Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
    Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
    Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
    J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-17 and tumour necrosis factor α combination induces a HIF-1α-dependent invasive phenotype in synoviocytes.
    Hot A; Zrioual S; Lenief V; Miossec P
    Ann Rheum Dis; 2012 Aug; 71(8):1393-401. PubMed ID: 22532631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
    Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
    Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.
    Varas A; Valencia J; Lavocat F; Martínez VG; Thiam NN; Hidalgo L; Fernández-Sevilla LM; Sacedón R; Vicente A; Miossec P
    Arthritis Res Ther; 2015 Jul; 17(1):192. PubMed ID: 26215036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes.
    Alquraini A; Jamal M; Zhang L; Schmidt T; Jay GD; Elsaid KA
    Arthritis Res Ther; 2017 May; 19(1):89. PubMed ID: 28482921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.